292 related articles for article (PubMed ID: 18845274)
21. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
[TBL] [Abstract][Full Text] [Related]
22. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
Rascati KL; Richards KM; Johnsrud MT; Mann TA
Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
[TBL] [Abstract][Full Text] [Related]
23. Quantifying the response to antiepileptic drugs: effect of past treatment history.
Schiller Y; Najjar Y
Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
[TBL] [Abstract][Full Text] [Related]
24. Pattern and frequency of use of complementary and alternative medicine among patients with epilepsy in the midwestern United States.
Liow K; Ablah E; Nguyen JC; Sadler T; Wolfe D; Tran KD; Guo L; Hoang T
Epilepsy Behav; 2007 Jun; 10(4):576-82. PubMed ID: 17459780
[TBL] [Abstract][Full Text] [Related]
25. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy.
Das S; Jiang X; Jiang W; Ting TY; Polli JE
Epilepsy Behav; 2020 Apr; 105():106936. PubMed ID: 32092462
[TBL] [Abstract][Full Text] [Related]
26. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
Bialer M; Midha KK
Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
[TBL] [Abstract][Full Text] [Related]
27. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
28. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
Makus KG; McCormick J
Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
[TBL] [Abstract][Full Text] [Related]
29. Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity?
Pack AM; Davis AR; Kritzer J; Yoon A; Camus A
Epilepsy Behav; 2009 Apr; 14(4):640-4. PubMed ID: 19435578
[TBL] [Abstract][Full Text] [Related]
30. Understanding routine antiepileptic drug decisions: a qualitative analysis of patients' accounts of hospital consultations.
McCorry D; Marson T; Jacoby A
Epilepsy Behav; 2009 Jan; 14(1):210-4. PubMed ID: 18977312
[TBL] [Abstract][Full Text] [Related]
31. Are generic drugs really inferior medicines?
Moore N; Berdaï D; Bégaud B
Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
[TBL] [Abstract][Full Text] [Related]
32. [Patients' experiences with and attitudes to generic substitution].
Kjønniksen I; Lindbaek M; Granås AG
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1682-4. PubMed ID: 15976842
[TBL] [Abstract][Full Text] [Related]
33. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
Contin M; Alberghini L; Candela C; Benini G; Riva R
Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
[TBL] [Abstract][Full Text] [Related]
34. Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.
Devine ST; Weisbart E; Barron J; Behm A
Curr Med Res Opin; 2010 Feb; 26(2):455-63. PubMed ID: 20014974
[TBL] [Abstract][Full Text] [Related]
35. Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database.
Hsieh LP; Huang CY
Epilepsy Res; 2009 Mar; 84(1):21-7. PubMed ID: 19135869
[TBL] [Abstract][Full Text] [Related]
36. Exercise and epilepsy: a survey of Midwest epilepsy patients.
Ablah E; Haug A; Konda K; Tinius AM; Ram S; Sadler T; Liow K
Epilepsy Behav; 2009 Jan; 14(1):162-6. PubMed ID: 18926931
[TBL] [Abstract][Full Text] [Related]
37. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
[TBL] [Abstract][Full Text] [Related]
38. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
Holtkamp M; Theodore WH
Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
[TBL] [Abstract][Full Text] [Related]
39. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
[TBL] [Abstract][Full Text] [Related]
40. Comparative effectiveness of generic versus brand-name antiepileptic medications.
Gagne JJ; Kesselheim AS; Choudhry NK; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Epilepsy Behav; 2015 Nov; 52(Pt A):14-8. PubMed ID: 26386779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
